Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on
February 12, 2013
Conference Call and Webcast to Follow
WASHINGTON, Jan. 22, 2013
WASHINGTON, Jan. 22, 2013 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA), a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous system
disorders, today announced it will release results for the fourth quarter of
2012 on Tuesday, February 12, 2013, before the market opens.
The Company will host a conference call at 10:00 AM ET on Tuesday, February
12, 2013, during which Vanda management will discuss the financial results.
To participate in the conference call, please dial 1-800-901-5248 (domestic)
or 1-617-786-4512 (international) and use passcode 86594010.
The conference call will be broadcast simultaneously and archived on the
Company's website, www.vandapharma.com. Investors should go to the website at
least 15 minutes early to register, download, and install any necessary audio
A replay of the call will be available on Tuesday, February 12, 2013,
beginning at 12:00 PM ET and will be accessible until Tuesday, February 19,
2013, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic
callers and 1-617-801-6888 for international callers. The passcode number is
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of central
nervous system disorders. For more on Vanda Pharmaceuticals Inc., please
Senior Communications Manager
Vanda Pharmaceuticals Inc.
SOURCE Vanda Pharmaceuticals Inc.
Press spacebar to pause and continue. Press esc to stop.